Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02348398 | Phase II Study of Pazopanib and Topotecan in Cervical Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 16, 2016 | clinicaltrials |
| NCT00829959 | Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) | completed | — | 156 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 4, 2016 | clinicaltrials |
| NCT00614653 | Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | completed | Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT02429544 | Effects of a Group Residential Retreat on Cancer Outcomes | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 1, 2016 | clinicaltrials |
| NCT00832715 | Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 120 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00473122 | Delayed-Immediate Breast Reconstruction | completed | Phase 2 | 200 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT01256528 | Delayed-Delayed Breast Reconstruction | completed | N/A | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT02357108 | Message: Study of Patients' Perception of Physician's Compassion | completed | N/A | 103 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00778375 | Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) | completed | Phase 2 | 122 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT01436084 | SB1518 for Patients With Myelodysplastic Syndrome (MDS) | terminated | Phase 2 | 8 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01532011 | Erlotinib in Combination With Pralatrexate in Advanced Malignancies | completed | Phase 1 | 72 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 4, 2016 | clinicaltrials |
| NCT00984997 | Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | completed | Phase 2 | 38 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT00826449 | Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 53 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT01320059 | Study of 18F-Fluoro-PEG6-IPQA | completed | Phase 1 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 27, 2016 | clinicaltrials |
| NCT00465179 | Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer | completed | Phase 2 | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT01079936 | Lenalidomide and High-Dose Melphalan | completed | Phase 1 / Phase 2 | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT00410982 | Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies | completed | Phase 1 | 145 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00904722 | Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma | completed | Phase 2 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 3, 2016 | clinicaltrials |
| NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) | completed | Phase 1 | 180 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00671606 | Hysteroscopic Lymphatic Mapping for Endometrial Cancer | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
| NCT01310829 | Virtual Reality Intervention in Cancer Genetics | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | May 26, 2016 | clinicaltrials |
| NCT00290537 | Phase II Study of ZD6474 in Advanced NSCLC | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT00766636 | Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT00512460 | RTA 744 Injection in Patients With Leptomeningeal Disease | terminated | Phase 1 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT00537199 | OraTest in Combination With Visual Examination and Visual Examination Alone | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT00558558 | Haelan and Nutrition in Cancer Patients | terminated | Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT01807286 | Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis | terminated | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT00050531 | High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML) | completed | Phase 3 | 94 | M.D. Anderson Cancer CenterOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT01092741 | Late Chronic Phase Chronic Myelogenous Leukemia | completed | Phase 2 | 47 | M.D. Anderson Cancer CenterOTHER | 1 | May 11, 2016 | clinicaltrials |
| NCT00063258 | Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT00352664 | The Effect of Donepezil on Sedation and Other Symptoms | terminated | Phase 3 | 27 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT00427791 | Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT00429403 | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT00502203 | Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | terminated | Phase 3 | 2 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT00634010 | Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain | terminated | Phase 3 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT01254890 | Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome | completed | Phase 1 / Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2016 | clinicaltrials |
| NCT02701673 | Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | May 4, 2016 | clinicaltrials |
| NCT01016028 | Chemotherapy-Induced Peripheral Neuropathy Survey | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | May 3, 2016 | clinicaltrials |
| NCT00481884 | Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients | completed | Phase 3 | 80 | M.D. Anderson Cancer CenterOTHER | 1 | May 2, 2016 | clinicaltrials |
| NCT00631241 | Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer | completed | N/A | 20 | M.D. Anderson Cancer CenterOTHER | 1 | May 2, 2016 | clinicaltrials |
| NCT00412581 | Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma | completed | Phase 1 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 29, 2016 | clinicaltrials |
| NCT00634894 | Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT00912912 | Sunitinib Malate in Refractory Germ Cell Tumors | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01894607 | Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy | completed | N/A | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT00479830 | Health and Cancer Issues in the South Asian Community | completed | — | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT01454804 | Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors | completed | Phase 1 | 43 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT01804335 | CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL) | completed | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 13, 2016 | clinicaltrials |
| NCT01117740 | Pleural Catheters Versus Thoracoscopic Pleurodesis | completed | — | 445 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT01490060 | Fosaprepitant in Patients Receiving Ifosfamide-based Regimen | completed | N/A | 47 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 11, 2016 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials